Course for Brain Fatigue After Graves' Disease Controlled Study

Launched by VASTRA GOTALAND REGION · Nov 10, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new program aimed at helping people with Graves' disease who experience mental fatigue. Mental fatigue is a common issue for these patients and can make it hard for them to focus, remember things, and feel emotionally balanced. The researchers want to see if a special course designed to address mental fatigue can improve patients' overall mental well-being, quality of life, and daily functioning compared to those who only receive standard medical care.

To be eligible for the trial, participants should be between 18 and 72 years old, have been diagnosed with Graves' disease within the last 15 to 72 months, and have normal thyroid hormone levels for the past six months. They should also be experiencing significant mental fatigue, as measured by a specific scoring system. Participants in the trial will be monitored over 12 months to evaluate the effects of the mental fatigue course, and the researchers hope this study will lead to better support and treatment options for patients dealing with the lingering effects of Graves' disease.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18-72 years old
• • 15-72 months since first Graves' diagnosis
• • high free thyroxin and thyroid antibodies (TRAb) at diagnosis
• • euthyroid the last 6 months normal thyroid hormone levels at inclusion
• • symptoms on MF in connection to Graves diagnosis
• • MF-scale ≥10.5 points
• Exclusion criteria:
• • other diseases or situations that may be associated with mental fatigue (such as other active inflammatory disease, neurological disease)
• • pregnancy
• • lactation
• • assessment that the patient cannot follow the study protocol.